| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
10-21-2012, 04:56 PM
|
#1 | |||
|
||||
|
Senior Member
|
Search offers
Use of GDNF splice variants in gene therapy of Parkinsonīs disease Country of origin: FINLAND Finnish researchers have characterized splice variants of neurotrophic protein GDNF with great potential use as target in gene therapy for the treatment of neurodegenerative disorders, especially Parkinsonīs Disease (PD). In animal model of PD, one new splice variant is more efficient in gene therapy than the one that has been used so far for GDNF gene therapy. Researchers seek licensees, technical cooperation with financial resources for joint further development towards preclinical studies... http://www.enterpriseeuropeni.com/in...nquiryType=BBS
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here it's just not very evenly distributed. William Gibson |
|||
|
 Reply With Quote
|
| "Thanks for this!" says: |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| MedGenesis Announces New Grant for the Development of GDNF | Parkinson's Disease | |||
| Ugghh-- journalism, drug industry's new dance partner | Parkinson's Disease | |||
| weight loss industry is a billion dollar industry | Weight Loss & Healthy Living | |||
| Development Of The Pharmaceutical Industry: How, Why, and When Corruption Came In | Parkinson's Disease | |||
| Epstein-Barr a precursor to MS | Multiple Sclerosis | |||
Industry partner sought for development GDNF precursor variant
Linear Mode
